Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Parkinson's Disease

Free Subscription 20.07.2026 1 BMC Neurosci 2 Exp Neurol 4 Lancet Neurol 1 Mov Disord 1 Neurobiol Dis 1 Neurochem Res 1 Neurologia (Engl Ed) 2 Neurology 1 Neuron 1 Neuroscience 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Neurosci

1. HWANG S, Choi H, Cho H, Ahn S, et al
   Leucettine L41 Ameliorates Tau pathology and neuroinflammation in Parkinson's disease models.
   BMC Neurosci. 2026 Jul 13. doi: 10.1186/s12868-026-01026.
   PubMed         Abstract available
   
   

   
   Exp Neurol

2. SUN T, Kim KS, Sun RA
   Physical activity and lncRNA-mediated regulation in Parkinson's disease: Mechanistic insights and translational perspectives.
   Exp Neurol. 2026;405:115910.
   PubMed         Abstract available
   
   
3. EDWARDS S, Loipersberger C, Arthur E, Collins-Praino L, et al
   Effects of pre-existing olfactory inflammation on Parkinson's disease related pathology following diffuse traumatic brain injury.
   Exp Neurol. 2026;405:115915.
   PubMed         Abstract available
   
   

   
   Lancet Neurol

4. LANGE LM, Fang ZH, Makarious MB, Kuznetsov N, et al
   Parkinson's disease genetics across diverse ancestries: an observational genetic study of causal and risk variants with translational implications.
   Lancet Neurol. 2026;25:741-754.
   PubMed         Abstract available
   
   
5. FERNANDEZ HH, Bhatia P, Cloud L, Fietzek UM, et al
   Safety, tolerability, and efficacy of flexible-dose tavapadon for Parkinson's disease (TEMPO-2): a phase 3, randomised, placebo-controlled, double-blind trial.
   Lancet Neurol. 2026;25:721-730.
   PubMed         Abstract available
   
   
6. BONIFATI V
   An important step towards delineating Parkinson's disease genetics worldwide.
   Lancet Neurol. 2026;25:705-706.
   PubMed        
   
   
7. RASCOL O, Fabbri M
   Tavapadon for the treatment of Parkinson's disease.
   Lancet Neurol. 2026;25:702-703.
   PubMed        
   
   

   
   Mov Disord

8. MULLER M, Rouleau EAMY, van der Gaag S, Zutt R, et al
   Decoding Finely Tuned Gamma Oscillations in Chronic Deep Brain Stimulation for Parkinson's Disease.
   Mov Disord. 2026 Jul 17. doi: 10.1002/mds.70419.
   PubMed         Abstract available
   
   

   
   Neurobiol Dis

9. HUANG CY, Chen LC, Wu RM, Hwang IS, et al
   Dual-tasking reveals severity-dependent reorganization of cortical beta energy landscapes in Parkinson's disease.
   Neurobiol Dis. 2026 Jul 16:107536. doi: 10.1016/j.nbd.2026.107536.
   PubMed         Abstract available
   
   

   
   Neurochem Res

10. MALESKI ALA, da Cunha E Silva FA, Pereira BF, Alberto-Silva C, et al
    BjPro-7a, A Proline-Rich Peptide from Bothrops jararaca Venom, Reverses MPP(+)-Induced Locomotor Deficits and Rescues Mitochondrial, Redox, and Synaptic Proteomic Pathways in a Zebrafish Model of Parkinsonism.
    Neurochem Res. 2026;51:214.
    PubMed         Abstract available
    
    

    
    Neurologia (Engl Ed)

11. PAGONABARRAGA MORA J, Blazquez Estrada M, Freire-Alvarez E, Lopez Manzanares L, et al
    Spanish expert consensus statement on the use of inhaled levodopa for the treatment of fluctuations in Parkinson's disease.
    Neurologia (Engl Ed). 2026 Jul 15:502040. doi: 10.1016/j.nrleng.2026.502040.
    PubMed         Abstract available
    
    

    
    Neurology

12. PERLMUTTER JS, Norris SA
    Parkinson Disease: Think Before You Step.
    Neurology. 2026;107:e218342.
    PubMed        
    
    
13. KIM SW, Lee MJ, Kim JW, Yoo J, et al
    Dual Dopaminergic and Limbic-Cognitive Contributions to Gait Parameters in De Novo Parkinson Disease.
    Neurology. 2026;107:e218223.
    PubMed         Abstract available
    
    

    
    Neuron

14. ALI M, Timsina J, Xu Y, Chen Y, et al
    Large-scale CSF and plasma proteomics reveal immune, synaptic, and extracellular matrix disruptions across neurodegenerative diseases.
    Neuron. 2026;114:2549-2565.
    PubMed         Abstract available
    
    

    
    Neuroscience

15. KALVALA S, Abushik P, Rezaie M, Dougalis A, et al
    Air-Liquid interface midbrain organoids model the pathological features of Parkinson's disease.
    Neuroscience. 2026 Jul 17:S0306-4522(26)00472.
    PubMed         Abstract available
    
    

    
    PLoS One

16. MONIER F, Droit-Volet S, Dambrun M, Monceau S, et al
    Parkinson's disease and awareness of the passage of time: Perceived health, emotion, and self-transcendence.
    PLoS One. 2026;21:e0352176.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum